Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 2/2009

01-03-2009 | Original Article

Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period

Authors: Kishiko Nakajima, Ken-ichi Umino, Yoshiaki Azuma, Seiichi Kosaka, Kazue Takano, Takao Obara, Kanji Sato

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2009

Login to get access

Abstract

The pathogenesis of primary hyperparathyroidism (I°-HPT) and secondary hyperparathyroidism (II°-HPT) remains to be elucidated. To characterize their pathophysiology, we investigated the effects of calcium and phosphate on cell proliferation and PTH release in an organ culture of parathyroid tissues. Dissected parathyroid tissues obtained from patients with I°-HPT (adenoma) or II°-HPT (nodular hyperplasia) were precultured on a collagen-coated membrane for 1–4 week. After changing the medium for one containing various concentrations of phosphate, PTH release and [3H]thymidine incorporation were studied. In contrast to dispersed parathyroid cells cultured in a monolayer, calcium decreased PTH release in a concentration-dependent manner in parathyroid tissues. Furthermore, when parathyroid tissues obtained from II°-HPT were precultured for 1–4 weeks, PTH release and parathyroid cell proliferation were significantly increased in high-phosphate medium. These phosphate effects were also observed to a lesser extent in parathyroid tissues obtained from I°-HPT, but there was no significant difference between I°-HPT and II°-HPT. Microarray analyses revealed that mRNA levels of PTH, CaSR, and VDR were well preserved, and several growth factors (e.g. TGF-beta1-induced protein) were abundantly expressed in II°-HPT. Using organ cultures of hyperparathyroid tissues, in which PTH release and CaSR are well preserved for a prolonged period, we have demonstrated that phosphate stimulates parathyroid cell proliferation not only in II°-HPT but also in I°-HPT. Although the mechanism responsible for phosphate-induced cell proliferation remains to be elucidated, our in vitro findings suggest that both parathyroid tissues preserve to some extent a physiological response system to hyperphosphatemia as observed in normal parathyroid cells.
Literature
1.
go back to reference Elder G (2002) Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 17:2094–2105PubMedCrossRef Elder G (2002) Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 17:2094–2105PubMedCrossRef
2.
go back to reference Rodriguez M, Nemeth E, Martin D (2005) The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 288:F253–F264PubMedCrossRef Rodriguez M, Nemeth E, Martin D (2005) The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 288:F253–F264PubMedCrossRef
3.
go back to reference Slatopolsky E, Brown A, Dusso A (2005) Calcium, phosphorus and vitamin D disorders in uremia. Contrib Nephrol 149:261–271PubMedCrossRef Slatopolsky E, Brown A, Dusso A (2005) Calcium, phosphorus and vitamin D disorders in uremia. Contrib Nephrol 149:261–271PubMedCrossRef
4.
go back to reference Silver J, Levi R (2005) Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 63:119–126PubMed Silver J, Levi R (2005) Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 63:119–126PubMed
5.
go back to reference Lee MJ, Roth SI (1975) Effect of calcium and magnesium on deoxyribonucleic acid synthesis in rat parathyroid glands in vitro. Lab Invest 33:72–79PubMed Lee MJ, Roth SI (1975) Effect of calcium and magnesium on deoxyribonucleic acid synthesis in rat parathyroid glands in vitro. Lab Invest 33:72–79PubMed
6.
go back to reference Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534–2540PubMedCrossRef Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534–2540PubMedCrossRef
7.
go back to reference Roussanne MC, Lieberherr M, Souberbielle JC, Sarfati E, Drueke T, Bourdeau A (2001) Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate. Eur J Clin Invest 31:610–616PubMedCrossRef Roussanne MC, Lieberherr M, Souberbielle JC, Sarfati E, Drueke T, Bourdeau A (2001) Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate. Eur J Clin Invest 31:610–616PubMedCrossRef
8.
go back to reference Nielsen PK, Feldt-Rasmussen U, Olgaard KA (1996) Direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 11:1762–1768PubMed Nielsen PK, Feldt-Rasmussen U, Olgaard KA (1996) Direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 11:1762–1768PubMed
9.
go back to reference Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M (1996) Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11:970–976PubMedCrossRef Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, Rodriguez M (1996) Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11:970–976PubMedCrossRef
10.
go back to reference Almaden Y, Hernandez A, Torregrosa V, Canalejo A, Sabate L, Fernandez Cruz L, Campistol JM, Torres A, Rodriguez M (1998) High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 9:1845–1852PubMed Almaden Y, Hernandez A, Torregrosa V, Canalejo A, Sabate L, Fernandez Cruz L, Campistol JM, Torres A, Rodriguez M (1998) High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol 9:1845–1852PubMed
11.
go back to reference Roussanne MC, Gogusev J, Hory B, Duchambon P, Souberbielle JC, Nabarra B, Pierrat D, Sarfati E, Drueke T, Bourdeau A (1998) Persistence of Ca2+-sensing receptor expression in functionally active, long-term human parathyroid cell cultures. J Bone Miner Res 13:354–362PubMedCrossRef Roussanne MC, Gogusev J, Hory B, Duchambon P, Souberbielle JC, Nabarra B, Pierrat D, Sarfati E, Drueke T, Bourdeau A (1998) Persistence of Ca2+-sensing receptor expression in functionally active, long-term human parathyroid cell cultures. J Bone Miner Res 13:354–362PubMedCrossRef
12.
go back to reference Liu W, Ridefelt P, Akerstrom G, Hellman P (2001) Differentiation of human parathyroid cells in culture. J Endocrinol 168:417–425PubMedCrossRef Liu W, Ridefelt P, Akerstrom G, Hellman P (2001) Differentiation of human parathyroid cells in culture. J Endocrinol 168:417–425PubMedCrossRef
13.
go back to reference Mithal A, Kifor O, Kifor I, Vassilev P, Butters R, Krapcho K, Simin R, Fuller F, Hebert SC, Brown EM (1995) The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2+ is associated with marked reduction in the expression of extracellular Ca(2+)-sensing receptor messenger ribonucleic acid and protein. Endocrinology 136:3087–3092PubMedCrossRef Mithal A, Kifor O, Kifor I, Vassilev P, Butters R, Krapcho K, Simin R, Fuller F, Hebert SC, Brown EM (1995) The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2+ is associated with marked reduction in the expression of extracellular Ca(2+)-sensing receptor messenger ribonucleic acid and protein. Endocrinology 136:3087–3092PubMedCrossRef
14.
go back to reference Sato K, Obara T, Yamazaki K, Kanbe M, Nakajima K, Yamada A, Yanagisawa T, Kato Y, Nishikawa T, Takano K (2001) Somatic mutations of the MEN1 gene and microsatellite instability in tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia. J Clin Endocrinol Metab 86:5564–5571PubMedCrossRef Sato K, Obara T, Yamazaki K, Kanbe M, Nakajima K, Yamada A, Yanagisawa T, Kato Y, Nishikawa T, Takano K (2001) Somatic mutations of the MEN1 gene and microsatellite instability in tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia. J Clin Endocrinol Metab 86:5564–5571PubMedCrossRef
15.
go back to reference Sato K, Nakajima K, Takano K, Obara T (2004) Gene expression in primary and secondary hyperparathyroidism: phosphate-induced genes in human parathyroid tissue in organ culture. J Bone Miner Res 19(suppl.1):S327 (abstract #SU 511) Sato K, Nakajima K, Takano K, Obara T (2004) Gene expression in primary and secondary hyperparathyroidism: phosphate-induced genes in human parathyroid tissue in organ culture. J Bone Miner Res 19(suppl.1):S327 (abstract #SU 511)
16.
go back to reference Sato K, Nakajima K, Takano K, Kosaka S, Obara T, Umino K, Azuma Y (2007) Phosphate stimulates greater PTH release and parathyroid cell proliferation in organ culture of parathyroid tissue from patients wit secondary hyperparathyroidism than with primary hyperparathyroidism: microarray analyses of phosphate-induced genes. J Bone Miner Res 22(suppl.1):S397 (abstract #W141) Sato K, Nakajima K, Takano K, Kosaka S, Obara T, Umino K, Azuma Y (2007) Phosphate stimulates greater PTH release and parathyroid cell proliferation in organ culture of parathyroid tissue from patients wit secondary hyperparathyroidism than with primary hyperparathyroidism: microarray analyses of phosphate-induced genes. J Bone Miner Res 22(suppl.1):S397 (abstract #W141)
17.
go back to reference Yamada E, Yamazaki K, Takano K, Obara T, Sato K (2006) Iodide inhibits vascular endothelial growth factor (VEGF)-A expression in cultured human thyroid follicles: a microarray search for effects of TSH and iodide on angiogenesis factors. Thyroid 16:545–554PubMedCrossRef Yamada E, Yamazaki K, Takano K, Obara T, Sato K (2006) Iodide inhibits vascular endothelial growth factor (VEGF)-A expression in cultured human thyroid follicles: a microarray search for effects of TSH and iodide on angiogenesis factors. Thyroid 16:545–554PubMedCrossRef
18.
go back to reference Yamazaki K, Suzuki K, Yamada E, Yamada T, Takeshita F, Matsumoto M, Mitsuhashi T, Obara T, Takano K, Sato K (2007) Suppression of iodide uptake and thyroid hormone synthesis with stimulation of type I interferon system by double-stranded RNA (dsRNA) in cultured human thyroid follicles. Endocrinology 148:3226–3235PubMedCrossRef Yamazaki K, Suzuki K, Yamada E, Yamada T, Takeshita F, Matsumoto M, Mitsuhashi T, Obara T, Takano K, Sato K (2007) Suppression of iodide uptake and thyroid hormone synthesis with stimulation of type I interferon system by double-stranded RNA (dsRNA) in cultured human thyroid follicles. Endocrinology 148:3226–3235PubMedCrossRef
19.
go back to reference Yamazaki K, Mitsuhashi T, Yamada E, Yamada T, Kosaka S, Takano K, Obara T, Sato K (2007) Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles. Thyroid 17:1189–1200PubMedCrossRef Yamazaki K, Mitsuhashi T, Yamada E, Yamada T, Kosaka S, Takano K, Obara T, Sato K (2007) Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles. Thyroid 17:1189–1200PubMedCrossRef
20.
go back to reference SAS Institute (1989) SAS/STAT User’s guide, version 6, fourth edition, volume1 and volume 2. SAS Institute, Cary SAS Institute (1989) SAS/STAT User’s guide, version 6, fourth edition, volume1 and volume 2. SAS Institute, Cary
21.
go back to reference Oka T, Yoshioka T, Shrestha GR, Koide T, Sonoda T, Hosokawa S, Onoe K, Sakurai M (1988) Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism. Virchows Arch A Pathol Anat Histopathol 413:53–360PubMedCrossRef Oka T, Yoshioka T, Shrestha GR, Koide T, Sonoda T, Hosokawa S, Onoe K, Sakurai M (1988) Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism. Virchows Arch A Pathol Anat Histopathol 413:53–360PubMedCrossRef
22.
go back to reference Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, Viacava P, Naccarato AG, Miccoli P, Kifor O, Brown EM, Pinchera A, Marcocci C (2000) Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85:4789–4794PubMedCrossRef Cetani F, Picone A, Cerrai P, Vignali E, Borsari S, Pardi E, Viacava P, Naccarato AG, Miccoli P, Kifor O, Brown EM, Pinchera A, Marcocci C (2000) Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85:4789–4794PubMedCrossRef
23.
go back to reference Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R (2000) Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58:1980–1986PubMedCrossRef Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R (2000) Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58:1980–1986PubMedCrossRef
24.
go back to reference Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A, Obuse C, Togashi K, Tominaga M, Kita N, Tomiyama K, Iijima J, Nabeshima Y, Fujioka M, Asato R, Tanaka S, Kojima K, Ito J, Nozaki K, Hashimoto N, Ito T, Nishio T, Uchiyama T, Fujimori T, Nabeshima Y (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316(5831):1615–1618PubMedCrossRef Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A, Obuse C, Togashi K, Tominaga M, Kita N, Tomiyama K, Iijima J, Nabeshima Y, Fujioka M, Asato R, Tanaka S, Kojima K, Ito J, Nozaki K, Hashimoto N, Ito T, Nishio T, Uchiyama T, Fujimori T, Nabeshima Y (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316(5831):1615–1618PubMedCrossRef
25.
go back to reference Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism— pivotal role of fibroblast growth factor 23. Intern Med 47:337–343PubMedCrossRef Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism— pivotal role of fibroblast growth factor 23. Intern Med 47:337–343PubMedCrossRef
26.
go back to reference Schorderet DF, Menasche M, Morand S, Bonnel S, Büchillier V, Marchant D, Auderset K, Bonny C, Abitbol M, Munier FL (2000) Genomic characterization and embryonic expression of the mouse Bigh3 (Tgfbi) gene. Biochem Biophys Res Commun 274:267–274PubMedCrossRef Schorderet DF, Menasche M, Morand S, Bonnel S, Büchillier V, Marchant D, Auderset K, Bonny C, Abitbol M, Munier FL (2000) Genomic characterization and embryonic expression of the mouse Bigh3 (Tgfbi) gene. Biochem Biophys Res Commun 274:267–274PubMedCrossRef
27.
go back to reference Hibi Y, Kambe F, Tominaga Y, Mizuno Y, Kobayashi H, Iwase K, Imai T, Seo H (2006) Up-regulation of the gene encoding protein kinase A type I alpha regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure. J Clin Endocrinol Metab 91:563–568PubMedCrossRef Hibi Y, Kambe F, Tominaga Y, Mizuno Y, Kobayashi H, Iwase K, Imai T, Seo H (2006) Up-regulation of the gene encoding protein kinase A type I alpha regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure. J Clin Endocrinol Metab 91:563–568PubMedCrossRef
28.
go back to reference Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297PubMed Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239–297PubMed
29.
go back to reference Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y (1993) Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443PubMedCrossRef Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y (1993) Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436–1443PubMedCrossRef
30.
go back to reference Tomioka H, Morita K, Hasegawa S, Omura K (2006) Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med 35:206–211PubMedCrossRef Tomioka H, Morita K, Hasegawa S, Omura K (2006) Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med 35:206–211PubMedCrossRef
31.
go back to reference Hourihan RN, O’Sullivan GC, Morgan JG (2003) Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 23(1A):161–165PubMed Hourihan RN, O’Sullivan GC, Morgan JG (2003) Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 23(1A):161–165PubMed
32.
go back to reference Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, Friess H, Buchler MW (2002) Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim Biophys Acta 1588:1–6PubMed Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, Friess H, Buchler MW (2002) Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim Biophys Acta 1588:1–6PubMed
33.
go back to reference Schwab K, Patterson LT, Aronow BJ, Luckas R, Liang HC, Potter SS (2003) A catalogue of gene expression in the developing kidney. Kidney Int 64:1588–1604PubMedCrossRef Schwab K, Patterson LT, Aronow BJ, Luckas R, Liang HC, Potter SS (2003) A catalogue of gene expression in the developing kidney. Kidney Int 64:1588–1604PubMedCrossRef
34.
go back to reference Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24:600–632PubMedCrossRef Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24:600–632PubMedCrossRef
35.
go back to reference Garcia de la Torre N, Buley I, Wass JAH, Jackson DG, Turner HE (2004) Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions. J Clin Endocrinol Metab 89:2890–2896PubMedCrossRef Garcia de la Torre N, Buley I, Wass JAH, Jackson DG, Turner HE (2004) Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions. J Clin Endocrinol Metab 89:2890–2896PubMedCrossRef
36.
go back to reference Lazzris AC, Tsleni-Balafouta S, Papathomas T, Brousalis T, Thomopoulou G, Agrogiannis G, Patsouris ES (2006) Immunohistochemical investigations of angiogenic factors in parathyroid proliferative lesions. Eur J Endocrinol 154:827–833CrossRef Lazzris AC, Tsleni-Balafouta S, Papathomas T, Brousalis T, Thomopoulou G, Agrogiannis G, Patsouris ES (2006) Immunohistochemical investigations of angiogenic factors in parathyroid proliferative lesions. Eur J Endocrinol 154:827–833CrossRef
37.
go back to reference Brown EM, Swartz SL (1985) Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands. Prostaglandins 29:35–46PubMedCrossRef Brown EM, Swartz SL (1985) Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands. Prostaglandins 29:35–46PubMedCrossRef
38.
go back to reference White JA, Ramshaw H, Taimi M, Stangle W, Zhang AM, Everingham S, Creighton S, Tam SP, Jones G, Petkovich M (2000) Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci USA 97:6403–6408PubMedCrossRef White JA, Ramshaw H, Taimi M, Stangle W, Zhang AM, Everingham S, Creighton S, Tam SP, Jones G, Petkovich M (2000) Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci USA 97:6403–6408PubMedCrossRef
39.
go back to reference Hellman P, Lieu W, Westin G, Torma H, Akerstrom G (1999) Vitamin D and retinoids in parathyroid glands (review). Int J Mol Med 3:355–361PubMed Hellman P, Lieu W, Westin G, Torma H, Akerstrom G (1999) Vitamin D and retinoids in parathyroid glands (review). Int J Mol Med 3:355–361PubMed
40.
go back to reference Bossis I, Stratakis CA (2004) Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 145:5452–5458PubMedCrossRef Bossis I, Stratakis CA (2004) Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 145:5452–5458PubMedCrossRef
Metadata
Title
Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period
Authors
Kishiko Nakajima
Ken-ichi Umino
Yoshiaki Azuma
Seiichi Kosaka
Kazue Takano
Takao Obara
Kanji Sato
Publication date
01-03-2009
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2009
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-008-0032-8

Other articles of this Issue 2/2009

Journal of Bone and Mineral Metabolism 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine